SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing renewed momentum driven by its integration into the AI narrative and significant growth in active user metrics. The community is actively debating its long-term potential as an infrastructure layer, with many participants focused on staking strategies and accumulating during periods of volatility.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA token is currently trending as community members aggressively debate its legitimacy, with many labeling the project a speculative grift that has lost significant value since inception. The discussion is heavily polarized by political sentiment, with investors venting frustration over poor returns while detractors cite the project as a clear example of meme coin volatility and celebrity-linked controversy.

Exchange Traded Concepts Trust - ROBO Global Robotics and Automation Index ETF

Exchange Traded Concepts Trust - ETCT ROBO Global Robotics and Automation Index ETF

ROBO is reaching new all-time highs as the robotics and automation sector gains momentum from strong demand for labor-saving technology, leading many in the community to label it a core long-term investment. Investors are actively discussing the integration of humanoid robotics and AI, with many choosing this ETF to gain diversified exposure to the secular growth of the machine era.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

Investors are actively weighing the long-term potential of the robotics and AI sector, with community discussion focused on its role in addressing labor shortages and industrial automation. Sentiment is split between those viewing the ETF as a strategic play on rapid technological adoption and others concerned about market volatility and current valuations.

Billions is the global human and AI network, built on mobile-first verification to scale the internet of value. We uniquely verify the identity and uniqueness of humans and AI agents, empowering users with personalized experiences and rewards.  ‍Our network is designed to be accessible, scalable, and anonymous, making trust between humans and AI seamless and intuitive for everyone.

TillBilly

The BILL crypto token is experiencing intense debate as investors weigh its aggressive momentum against concerns surrounding its circulating supply and potential market manipulation. Community sentiment is deeply divided, with some highlighting its breakout potential as a successor to similar high-volatility assets while others warn of significant downside risks.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is currently trending as investors focus on its strategic pivot from Bitcoin mining to high-density AI and HPC data center infrastructure, highlighted by its 4.5GW power pipeline and multi-billion dollar hyperscale contracts. The community is actively debating the company's ability to execute on its long-duration lease agreements and whether its current valuation captures the full potential of its energy-backed data center assets following a significant institutional rotation toward energy-intensive infrastructure plays.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is generating significant community buzz following the elimination of gas fees for transfers on its mainnet, a development seen as a major catalyst for stablecoin adoption. Traders are actively debating the token's technical positioning near resistance levels, with many focusing on its potential for long-term growth and its ability to attract institutional interest.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing high volatility as investors debate its potential for a rally, with community sentiment deeply polarized between bullish speculators targeting price recovery and vocal critics dismissing it as a stagnant project. Active discussions are heavily focused on historical price cycles, staking rewards versus inflation, and a broader search for potential catalysts in the altcoin sector.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is gaining significant market attention as a specialized edge data center provider that offers modular, scalable infrastructure capable of deploying compute capacity in underserved regions, effectively bypassing the power grid and supply chain bottlenecks hindering massive data center projects. Community discussions are heavily focused on the company's potential to capture the rapidly growing AI inference market, noting its strategic partnerships, recent contract wins, and its unique ability to provide low-latency solutions in rural and localized settings.

Invesco CurrencyShares Euro Trust - Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust is trending as market participants closely monitor a combination of geopolitical tensions, including potential US-Iran conflict and trade policy shifts, alongside evolving central bank interest rate expectations. The community is actively discussing the euro's resilience against the dollar as traders navigate technical support levels, shifting economic data, and overall market sentiment regarding global growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Average Recommendation of "Buy" by Brokerages

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the eight ratings firms that are covering the company, Marketbeat reports. One...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Consensus Rating of "Buy" by Analysts

Shares of Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) have earned an average rating of "Buy" from the eight analysts that are presently covering the company, MarketBeat reports. One...

HC Wainwright Issues Positive Estimate for IKT Earnings

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Free Report) - Equities researchers at HC Wainwright increased their Q1 2026 earnings per share estimates for Inhibikase Therapeutics in a research report...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Average Rating of "Buy" by Analysts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) has received a consensus recommendation of "Buy" from the six ratings firms that are presently covering the firm, Marketbeat Ratings...

Inhibikase Therapeutics (NASDAQ:IKT) Upgraded to "Strong-Buy" at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH upgraded Inhibikase Therapeutics to a "strong-buy" rating in a report on Wednesday...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Short Interest Update

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling...

Inhibikase Therapeutics (NYSE:IKT) Coverage Initiated at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH initiated coverage on Inhibikase Therapeutics in a research report on Wednesday. They set a "buy" rating and a $4.00 target price for the company...

FY2025 Earnings Forecast for IKT Issued By Lifesci Capital

Inhibikase Therapeutics, Inc. (NYSE:IKT - Free Report) - Stock analysts at Lifesci Capital issued their FY2025 earnings per share estimates for Inhibikase Therapeutics in a report issued on Monday...

Inhibikase Therapeutics (NYSE:IKT) Trading Up 4.4% - Still a Buy?

Inhibikase Therapeutics (NYSE:IKT) Stock Price Up 4.4% - Time to Buy...

Inhibikase Therapeutics (NASDAQ:IKT) Upgraded by Lifesci Capital to "Strong-Buy" Rating

Lifesci Capital raised Inhibikase Therapeutics to a "strong-buy" rating in a report on Monday...

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Wilmington, DE.

IKT
Inhibikase Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest IKT News

IKTInhibikase Therapeutics Inc